FY2024 guidance has been revised upward, with revenue growth of 11% projected across the three primary segments. Adjusted EBITA for FY2024 is expected to rise year-over-year, driven by strong ...

Altria Group, Inc. struggles with declining market share despite exceeding Q4 2024 expectations. Click for my updated look at ...

Liquidia Corporation's litigation battle and upcoming commercial launch of its primary candidate, YUTREPIA, take spotlight.

Alphabet Inc.'s strong Q3 results and leadership in digital advertising, AI, and cloud position it for double-digit earnings ...

AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030.

Financial writer sees positive prospects for Alibaba's cloud computing business but warns of competition from other AI ...

Super Micro shares continue their march downwards, down 40%+ in the last 12 months. Click here to read an analysis of SMCI ...

Tesla appears overvalued again and recommend trimming TSLA due to overly optimistic projections around future products. Click ...

Deckers Outdoor reported strong Q3 2025 results, with significant growth in its UGG and Hoka brands. Click here to find out ...

AbbVie reported strong Q4 results, driven by Skyrizi, Rinvoq, neuroscience products, and eye care. Click here to find out why ...

ASML reported strong Q4 earnings, driven by AI chip demand, with revenue and EPS beating consensus estimates. Click here to ...

Warner Bros. recent developments, including Comcast's new skinny bundle excluding key Turner networks, raise concerns about ...